Skip to main content
Fig. 5 | BioData Mining

Fig. 5

From: A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer

Fig. 5

Identificantion of Genistein target subnetwork synergistics and enhancers in the MEK5/ERK5 pathway in breast cancer. A A summary of the analysis strategy employed for this analysis showing the key steps from drug data acquisition and processing to candidate drug identification. B A plot showing the scores from potential synergistic and C) network enhancer drugs obtained by using network proximity score + GO Term similarity (Closest_Score + GOSIM) and network proximity score + GO term similarity + orthogonality score (Final Score) under different doses

Back to article page

BioData Mining

ISSN: 1756-0381